About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT01645995

The Impact of Reformulated Foods on Cardiovascular Risk Factors

Specific policies on obesity reduction often include a recommendation to reduce sugar consumption as a means of lowering overall caloric intake. Reformulating processed foods (e.g. sugary products) is...

Lead sponsor: University of Reading•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of Reading

Age

20 - 49 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Age: 20 - 49 years
•BMI 18.5 - 30 kg/m2
•Plasma glucose \<7 mmol/l (Not diagnosed with diabetes)
•Plasma cholesterol \<7 mmol/l
•Plasma TAG \<2.3 mmol/l
•Normal liver and kidney function
•Haemoglobin (\>110 g/l women; 140g/dl men)

Exclusion Criteria

•Having suffered a myocardial infarction/stroke in the past 12 months
•diabetic (diagnosed or fasting glucose \> 7 mmol/l)
•Smoking
•On drug treatment for hyperlipidaemia, hypertension, inflammation or hypercoagulation
•Suffering from renal or bowel disease or have a history of choleostatic liver or pancreatitis
•Excessive alcohol consumption
•History of alcohol abuse
•Following a reducing diet or vegan diet
•Taking any fish oil, fatty acid or vitamin and mineral supplements
•Participating in intensive aerobic activity for \> 20 minutes 3 times per week
•Food allergies
•Anti-inflammatory usage

Related studies

Five PLus Year EffIcacy of Endoscopic Sleeve Gastroplasty (ESG) for Sustained WeigHT Loss

NCT06894498 · Obesity and Obesity-related Medical Conditions, Weight Loss

Health Ahead Comparative Effectiveness Study

NCT07669168 · Health Services Accessibility, Rural Health, and more

RECRUITINGPhase 3

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

NCT07136012 · Cardiovascular Disease

Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes

NCT05124808 · Gestational Diabetes, Pregnancy, High Risk, and more

Real-life Registry in Patients With Coronary Artery Disease Treated With the SELUTION Sirolimus-eluting Balloon. Selution Iberia Registry

NCT07256249 · Cardiovascular Diseases

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 4, 2014Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment50

Start dateMar 2012

Last updatedDec 4, 2014

Condition

Type 2 Diabetes Mellitus Cardiovascular Disease Obesity

Locations shown

Department of Food and Nutritional Sciences, University of Reading

Reading, Berks

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 4, 2014Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions